VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MODD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MODDModular Medical, Inc.
$4.94$10M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

MODD logoModular Medical, Inc.(MODD)Earnings, Financials & Key Ratios

MODD•NASDAQ
$4.94
Price updated Jun 27, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDiabetes care and insulin delivery
AboutModular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.Show more
  • Revenue$0
  • EBITDA-$18M-5.2%
  • Net Income-$19M-7.8%
  • EPS (Diluted)-15.30+34.6%
  • ROE-131.58%+37.4%

MODD Price & Volume

Modular Medical, Inc. (MODD) stock price & volume — 10-year historical chart

Loading chart...

Persistent Cash Burn Threatens Commercial Development Runway

Investment Thesis • Updated 2026Q3

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Regulatory and liquidity dependency

Key Thesis Takeaways

  • Modular Medical remains in a high-risk, pre-revenue development phase characterized by escalating R&D expenditures that have reached $5.4 million per quarter as of 2026Q3.
  • The company's reliance on stock-based compensation to preserve liquidity, which peaked at $813,000 in 2026Q2, suggests significant dilution risks for shareholders.
  • Investors should monitor the firm's ability to achieve commercial viability before its dwindling cash reserves, currently at $2.9 million, force a dilutive capital raise.

Verdict Logic

the company's precarious liquidity position, evidenced by a cash balance of only $2.9 million against a quarterly burn rate of approximately $7 million, suggests a high probability of near-term capital dilution.

MODD Growth Metrics

Modular Medical, Inc. (MODD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-47.32%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM7.55%

Return on Capital

10 Years-194.24%
5 Years-312.74%
3 Years-166.45%
Last Year-127.74%

MODD Recent Earnings

Modular Medical, Inc. (MODD) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/12 qtrs (17%)
Q1 2026Latest
Feb 17, 2026
Metric
Actual
Est
EPS
$3.30-10.0%
$3.00
Rev
—
$800,000
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$0.14-40.0%
$0.10
Rev
—
$400,000
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$0.12-20.0%
$0.10
Rev
—
$200,000
Q3 2025
Jun 20, 2025
Metric
Actual
Est
EPS
$0.12-9.1%
$0.11
Rev
—
$400,000
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 17, 2026
$3.30vs $3.00-10.0%
—vs $800,000
Q4 2025Nov 14, 2025
$0.14vs $0.10-40.0%
—vs $400,000
Q3 2025Aug 14, 2025
$0.12vs $0.10-20.0%
—vs $200,000
Q3 2025Jun 20, 2025
$0.12vs $0.11-9.1%
—vs $400,000
Based on last 12 quarters of dataView full earnings history →

Latest MODD News

Recent stock market news and headlines for Modular Medical, Inc. (MODD)

Accesswire·3 days ago
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps

Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery technology, today announced that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks.

Accesswire·5 days ago
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion

The Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in April Pivot represents a differentiated solution for insulin-dependent adults still on multiple daily injections, representing a multi-billion-dollar market Commercial expansion activities are expected to begin in Q4 2026 SAN DIEGO, CA / ACCESS Newswire / June 24, 2026 / Modular Medical, Inc. (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company's transition to a commercial-stage medical device company.

Peers Comparison

Key metrics vs top competitors for Modular Medical, Inc. (MODD)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
MODD logoMODDModular Medical, Inc.Current
$4.94$10.42M-0.32——-131.58%—
PODD logoPODDInsulet Corporation
$158.25$11.11B45.4730.73%10.44%21.38%—
TNDM logoTNDMTandem Diabetes Care, Inc.
$16.24$1.11B-5.347.93%-9.2%-68.29%—
NVCR logoNVCRNovoCure Limited
$15.43$1.76B-12.658.28%-25.66%-50.82%—
MASI logoMASIMasimo Corporation
$179.95$9.42B-64.27-27.1%4.9%9.08%—
DXCM logoDXCMDexCom, Inc.
$70.14$27.07B33.5615.6%19.31%33.83%—

Compare MODD vs Peers

Modular Medical, Inc. (MODD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PODD

Most directly comparable listed peer for MODD.

Scale Benchmark

vs LLY

Larger-name benchmark to compare MODD against a more recognizable public peer.

Peer Set

Compare Top 5

vs PODD, TNDM, NVCR, MASI

MODD SEC Filings & Documents

Modular Medical, Inc. (MODD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 20, 2026·SEC

Material company update

Apr 21, 2026·SEC

Material company update

Apr 16, 2026·SEC

10-K Annual Reports

3
FY 2025

Jun 20, 2025·SEC

FY 2024

Jun 21, 2024·SEC

FY 2023

Jun 26, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Feb 17, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 14, 2025·SEC

Get notified when MODD posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

MODD Frequently Asked Questions

Modular Medical, Inc. (MODD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
Is MODD profitable?

Modular Medical, Inc. (MODD) reported a net loss of $26.8M for fiscal year 2025.

Dividend & Returns
What is MODD's return on equity?

Modular Medical, Inc. (MODD) has a return on equity (ROE) of -131.6%. Negative ROE indicates the company is unprofitable.

What is Modular Medical, Inc.'s free cash flow?

Modular Medical, Inc. (MODD) had negative free cash flow of $26.1M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in MODD back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →